Synapse Open Synapse
Biology

Sanofi stops development of Nurix-partnered immune drug

BioPharma Dive · · 2 min read

The decision sparked a sell-off in Nurix shares as well as analyst debate about the prospects of drugs designed to degrade a tough-to-reach protein called STAT6.

Latest from BioPharma Dive